Moderna shares are trading lower. The stock may be down on continued weakness following Pfizer's warning about reduced COVID-19 product demand. However, Moderna reaffirmed its COVID vaccine sales forecast for the year.
Portfolio Pulse from Benzinga Newsdesk
Moderna's shares are trading lower possibly due to Pfizer's warning about reduced COVID-19 product demand. However, Moderna has reaffirmed its COVID vaccine sales forecast for the year.
October 17, 2023 | 5:04 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Moderna's stock is trading lower possibly due to Pfizer's warning about reduced COVID-19 product demand. However, Moderna has reaffirmed its vaccine sales forecast.
Moderna's stock is trading lower, which could be a reaction to Pfizer's warning about reduced demand for COVID-19 products. This suggests that investors may be concerned about potential impacts on Moderna's sales. However, Moderna has reaffirmed its vaccine sales forecast for the year, which could mitigate some of these concerns.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100